doi:10.1016/j.eurpsy.2016.01.2052
Popular GLP-1 drugs may lead to increased risk of gastrointestinal problems, study found Patients on GLP-1 drugs were over 9x more likely to develop pancreatitis than those on another weight management medication
In a meta-analysis with patients with T1D, weight loss with liraglutide 1.8 mg was estimated at ~5 kg compared to placebo (62), and there was a dose-response effect
Compounded semaglutide through telehealth providers is typically $150$350/month
Of semaglutide drugs, only Wegovy has received Other semaglutide and liraglutide drugs are used for weight management only in an The new study was a randomized, controlled trial conducted in Copenhagen, including 166 adults with obesity ranging from 18 to 65 years of age
Individual results may vary significantly based on health status, injury type, and other factors